Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3393075
Max Phase: Preclinical
Molecular Formula: C16H15N5
Molecular Weight: 277.33
Molecule Type: Small molecule
Associated Items:
ID: ALA3393075
Max Phase: Preclinical
Molecular Formula: C16H15N5
Molecular Weight: 277.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(N(C)C)n2nc3nc4ccccc4cc3c2n1
Standard InChI: InChI=1S/C16H15N5/c1-10-8-14(20(2)3)21-16(17-10)12-9-11-6-4-5-7-13(11)18-15(12)19-21/h4-9H,1-3H3
Standard InChI Key: URGRXBQQLOXSGV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 277.33 | Molecular Weight (Monoisotopic): 277.1327 | AlogP: 2.81 | #Rotatable Bonds: 1 |
Polar Surface Area: 46.32 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.45 | CX LogP: 2.84 | CX LogD: 2.84 |
Aromatic Rings: 4 | Heavy Atoms: 21 | QED Weighted: 0.54 | Np Likeness Score: -1.32 |
1. Karthikeyan C, Lee C, Moore J, Mittal R, Suswam EA, Abbott KL, Pondugula SR, Manne U, Narayanan NK, Trivedi P, Tiwari AK, Tiwari AK.. (2015) IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells., 23 (3): [PMID:25537531] [10.1016/j.bmc.2014.11.043] |
Source(1):